# ACP1

## Overview
The ACP1 gene encodes the enzyme acid phosphatase 1, a low molecular weight protein tyrosine phosphatase (LMW-PTP) that plays a significant role in cellular signaling and metabolism. This enzyme is involved in the dephosphorylation of phosphotyrosine residues on proteins, thereby modulating key signaling pathways, including those related to insulin receptor activity and energy metabolism (Iannaccone2005Serum; GloriaBottini1996Phosphotyrosine). The ACP1 gene is polymorphic, resulting in multiple isoforms that exhibit distinct biochemical properties and catalytic functions (Dissing1991Human). These isoforms contribute to the regulation of metabolic processes and have been implicated in various clinical conditions, such as type 1 diabetes, obesity, and immune response modulation (DocoFenzy2013Earlyonset; GloriaBottini2010Is). The enzyme's activity and genetic variations are of particular interest in understanding its role in disease susceptibility and metabolic regulation (De2009A).

## Structure
The ACP1 gene encodes a low molecular weight acid phosphatase that is polymorphic, resulting in multiple isoforms due to alternative splicing. The primary structure of the ACP1 protein consists of 157 amino acid residues, with eight cysteine residues that are present as free sulfhydryls in the reducing environment of the cytosol (Dissing1991Human). The protein is acetylated at the amino-terminal alanine (Dissing1991Human). 

The ACP1 protein has two main isoforms, Bf and Bs, which differ significantly in the sequence segment between residues 40-73. This segment is a signature sequence for each isozyme, with the Bs isozyme containing an additional basic residue, His-69, which influences its anodal mobility and catalytic function (Dissing1991Human). The Bs isozyme also exhibits a higher capacity for hydrophobic interaction, contributing to its greater stability compared to the Bf isozyme (Dissing1991Human).

The ACP1 protein shares a high degree of homology with a low molecular weight acid phosphatase from bovine liver, indicating a conserved structure and function across species (Dissing1991Human). The sequence segment Cys12-Leu-Gly-Asn-Ile-Cys17 resembles a sequence found near the active site of protein tyrosine phosphatases, suggesting a potential active site function for the cysteine residues (Dissing1991Human).

## Function
The ACP1 gene encodes for the enzyme acid phosphatase locus 1, also known as low molecular weight protein tyrosine phosphatase (LMPTP). This enzyme is involved in several molecular processes, primarily functioning as a protein tyrosine phosphatase and a flavin mononucleotide phosphatase. As a protein tyrosine phosphatase, ACP1 plays a crucial role in modulating insulin receptor activities by hydrolyzing phosphotyrosine-containing peptides, which can influence insulin signaling and glycolytic rates in cells (Iannaccone2005Serum; GloriaBottini1996Phosphotyrosine). This activity is significant in regulating cellular growth and energy metabolism, as well as in controlling receptor signaling pathways (De2009A).

ACP1 is polymorphic, with different genotypes exhibiting varying enzyme activities, which can affect glucose metabolism and insulin sensitivity. The enzyme's activity is associated with glycemic control, particularly in contexts such as diabetic pregnancy, where variations in ACP1 activity correlate with different levels of glycemic control (GloriaBottini1996Phosphotyrosine). Additionally, ACP1 is involved in the regulation of metabolic signaling, particularly in pathological situations where other control systems may fail, and is associated with conditions such as severe obesity and lipid level regulation (De2009A).

## Clinical Significance
Mutations and alterations in the expression of the ACP1 gene have been linked to a variety of human diseases. ACP1 encodes a low molecular weight protein tyrosine phosphatase (LMW-PTP), which plays a role in dephosphorylating proteins involved in immune and metabolic pathways. Variants of the ACP1 gene have been associated with increased susceptibility to type 1 diabetes (T1D), particularly the ACP1*A/ADA1*2 gametic type, which is linked to weakened T-cell receptor signaling and autoimmune disease susceptibility (GloriaBottini2010Is). 

ACP1 polymorphisms have also been implicated in the development of antibodies against platelet factor 4-heparin complexes, which are involved in heparin-induced thrombocytopenia (HIT). Genotypes associated with higher LMW-PTP activity are more common in patients with high levels of these antibodies, suggesting a role in immune response modulation (Rollin2013Impact).

Additionally, deletions involving the ACP1 gene have been observed in patients with early-onset obesity, intellectual disability, and behavioral issues, indicating a potential contribution to these conditions (DocoFenzy2013Earlyonset). The ACP1 gene's involvement in various diseases underscores its clinical significance and the need for further research to elucidate the underlying mechanisms.


## References


[1. (Rollin2013Impact) J. Rollin, C. Pouplard, D. Leroux, M.‐A. May, and Y. Gruel. Impact of polymorphisms affecting the acp1 gene on levels of antibodies against platelet factor 4–heparin complexes. Journal of Thrombosis and Haemostasis, 11(8):1609–1611, August 2013. URL: http://dx.doi.org/10.1111/jth.12278, doi:10.1111/jth.12278. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jth.12278)

[2. (Iannaccone2005Serum) Umberto Iannaccone, Antonio Bergamaschi, A. Magrini, Giuseppe Marino, Nunzio Bottini, Paola Lucarelli, Egidio Bottini, and Fulvia Gloria-Bottini. Serum glucose concentration and acp1 genotype in healthy adult subjects. Metabolism, 54(7):891–894, July 2005. URL: http://dx.doi.org/10.1016/j.metabol.2005.02.002, doi:10.1016/j.metabol.2005.02.002. This article has 24 citations.](https://doi.org/10.1016/j.metabol.2005.02.002)

[3. (De2009A) Antonino De Lorenzo, Laura Di Renzo, Alberto Puja, Patrizia Saccucci, Fulvia Gloria-Bottini, and Egidio Bottini. A study of acid phosphatase locus 1 in women with high fat content and normal body mass index. Metabolism, 58(3):351–354, March 2009. URL: http://dx.doi.org/10.1016/j.metabol.2008.10.007, doi:10.1016/j.metabol.2008.10.007. This article has 6 citations.](https://doi.org/10.1016/j.metabol.2008.10.007)

[4. (Dissing1991Human) J. Dissing, A.H. Johnsen, and G.F. Sensabaugh. Human red cell acid phosphatase (acp1). the amino acid sequence of the two isozymes bf and bs encoded by the acp1*b allele. Journal of Biological Chemistry, 266(31):20619–20625, November 1991. URL: http://dx.doi.org/10.1016/s0021-9258(18)54754-2, doi:10.1016/s0021-9258(18)54754-2. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)54754-2)

[5. (DocoFenzy2013Earlyonset) Martine Doco-Fenzy, Camille Leroy, Anouck Schneider, Florence Petit, Marie-Ange Delrue, Joris Andrieux, Laurence Perrin-Sabourin, Emilie Landais, Azzedine Aboura, Jacques Puechberty, Manon Girard, Magali Tournaire, Elodie Sanchez, Caroline Rooryck, Agnès Ameil, Michel Goossens, Philippe Jonveaux, Geneviève Lefort, Laurence Taine, Dorothée Cailley, Dominique Gaillard, Bruno Leheup, Pierre Sarda, and David Geneviève. Early-onset obesity and paternal 2pter deletion encompassing the acp1, tmem18, and myt1l genes. European Journal of Human Genetics, 22(4):471–479, October 2013. URL: http://dx.doi.org/10.1038/ejhg.2013.189, doi:10.1038/ejhg.2013.189. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2013.189)

[6. (GloriaBottini1996Phosphotyrosine) F. Gloria-Bottini, G. Gerlini, N. Lucarini, P. Borgiani, A. Amante, M. La Torre, E. Antonacci, and E. Bottini. Phosphotyrosine protein phosphatase and diabetic pregnancy: an association between low molecular weight acid phosphatase and degree of glycemic control. Cellular and Molecular Life Sciences, 52(4):340–343, April 1996. URL: http://dx.doi.org/10.1007/bf01919537, doi:10.1007/bf01919537. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/bf01919537)

[7. (GloriaBottini2010Is) Fulvia Gloria-Bottini, Patrizia Saccucci, Andrea Magrini, and Egidio Bottini. Is there a role of acp1-ada1 genetic complex in immune reaction? association with t1d and with past malarial morbidity. The American Journal of the Medical Sciences, 340(4):268–270, October 2010. URL: http://dx.doi.org/10.1097/MAJ.0b013e3181e62ae6, doi:10.1097/maj.0b013e3181e62ae6. This article has 6 citations.](https://doi.org/10.1097/MAJ.0b013e3181e62ae6)